Pharma & Healthcare
Global Recombinant Proteins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 344446
- Pages: 143
- Figures: 134
- Views: 7
In 2024, the global market size of Recombinant Proteins was estimated to be worth US$ 1244 million and is forecast to reach approximately US$ 2896 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Recombinant Proteins in global and regional level.
Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Proteins revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Recombinant Proteins in global and regional level.
Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Proteins revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Recombinant Proteins Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Proteins Market Size Estimates and Forecasts
2.2 Recombinant Proteins Market Size by Region: 2024 Versus 2031
2.2.1 Global Recombinant Proteins Revenue by Region: 2020-2025
2.2.2 Global Recombinant Proteins Revenue Forecast by Region (2026-2031)
2.2.3 Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Recombinant Proteins Revenue by Type (2020-2031)
3.1.2 Global Recombinant Proteins Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Recombinant Proteins Revenue by Application (2020-2031)
3.2.2 Global Recombinant Proteins Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Hormones of Recombinant Proteins Revenue Market Share by Application
3.3.2 Growth Factors of Recombinant Proteins Revenue Market Share by Application
3.3.3 Cytokines of Recombinant Proteins Revenue Market Share by Application
3.3.4 Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application
3.3.5 Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application
3.3.6 Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application
3.3.7 Others of Recombinant Proteins Revenue Market Share by Application
4 Global Recombinant Proteins by Company
4.1 Global Recombinant Proteins Revenue by Company (2020-2025)
4.2 Global Recombinant Proteins Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Recombinant Proteins Companies around the World: Ranking by Revenue
4.3.2 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Recombinant Proteins Companies Headquarters & Product Type
4.4.1 Global Recombinant Proteins Companies Headquarters
4.4.2 Date of International Companies Enter into Recombinant Proteins Market
4.4.3 Global Recombinant Proteins Companies Product & Service
4.4.4 Hormones Revenue Market Share of Recombinant Proteins by Company
4.4.5 Growth Factors Revenue Market Share of Recombinant Proteins by Company
4.4.6 Cytokines Revenue Market Share of Recombinant Proteins by Company
4.4.7 Plasma Protein Factor Revenue Market Share of Recombinant Proteins by Company
4.4.8 Recombinant Metabolic Enzymes Revenue Market Share of Recombinant Proteins by Company
4.4.9 Immune Checkpoint Regulators Revenue Market Share of Recombinant Proteins by Company
4.4.10 Others Revenue Market Share of Recombinant Proteins by Company
4.5 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bio-Techne Corporation
5.1.1 Bio-Techne Corporation Corporation Information
5.1.2 Bio-Techne Corporation Description, Business Overview
5.1.3 Bio-Techne Corporation Recombinant Proteins Products Offered
5.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.1.5 Bio-Techne Corporation Recombinant Proteins Revenue by Product in 2024
5.1.6 Bio-Techne Corporation Recombinant Proteins Revenue by Application in 2024
5.1.7 Bio-Techne Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.1.8 Bio-Techne Corporation Recent Developments
5.2 Abcam PLC
5.2.1 Abcam PLC Corporation Information
5.2.2 Abcam PLC Description, Business Overview
5.2.3 Abcam PLC Recombinant Proteins Products Offered
5.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.2.5 Abcam PLC Recombinant Proteins Revenue by Product in 2024
5.2.6 Abcam PLC Recombinant Proteins Revenue by Application in 2024
5.2.7 Abcam PLC Recombinant Proteins Revenue by Geographic Area in 2024
5.2.8 Abcam PLC Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Corporation Information
5.3.2 Merck KGaA Description, Business Overview
5.3.3 Merck KGaA Recombinant Proteins Products Offered
5.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.3.5 Merck KGaA Recombinant Proteins Revenue by Product in 2024
5.3.6 Merck KGaA Recombinant Proteins Revenue by Application in 2024
5.3.7 Merck KGaA Recombinant Proteins Revenue by Geographic Area in 2024
5.3.8 Merck KGaA Recent Developments
5.4 Miltenyi Biotec
5.4.1 Miltenyi Biotec Corporation Information
5.4.2 Miltenyi Biotec Description, Business Overview
5.4.3 Miltenyi Biotec Recombinant Proteins Products Offered
5.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.4.5 Miltenyi Biotec Recombinant Proteins Revenue by Product in 2024
5.4.6 Miltenyi Biotec Recombinant Proteins Revenue by Application in 2024
5.4.7 Miltenyi Biotec Recombinant Proteins Revenue by Geographic Area in 2024
5.4.8 Miltenyi Biotec Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Corporation Information
5.5.2 Thermo Fisher Scientific Description, Business Overview
5.5.3 Thermo Fisher Scientific Recombinant Proteins Products Offered
5.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.5.5 Thermo Fisher Scientific Recombinant Proteins Revenue by Product in 2024
5.5.6 Thermo Fisher Scientific Recombinant Proteins Revenue by Application in 2024
5.5.7 Thermo Fisher Scientific Recombinant Proteins Revenue by Geographic Area in 2024
5.5.8 Thermo Fisher Scientific Recent Developments
5.6 ACROBiosystems
5.6.1 ACROBiosystems Corporation Information
5.6.2 ACROBiosystems Description, Business Overview
5.6.3 ACROBiosystems Recombinant Proteins Products Offered
5.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.6.5 ACROBiosystems Recombinant Proteins Revenue by Product in 2024
5.6.6 ACROBiosystems Recombinant Proteins Revenue by Application in 2024
5.6.7 ACROBiosystems Recombinant Proteins Revenue by Geographic Area in 2024
5.6.8 ACROBiosystems Recent Developments
5.7 Sino Biological
5.7.1 Sino Biological Corporation Information
5.7.2 Sino Biological Description, Business Overview
5.7.3 Sino Biological Recombinant Proteins Products Offered
5.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.7.5 Sino Biological Recombinant Proteins Revenue by Product in 2024
5.7.6 Sino Biological Recombinant Proteins Revenue by Application in 2024
5.7.7 Sino Biological Recombinant Proteins Revenue by Geographic Area in 2024
5.7.8 Sino Biological Recent Developments
5.8 Cytiva
5.8.1 Cytiva Corporation Information
5.8.2 Cytiva Description, Business Overview
5.8.3 Cytiva Recombinant Proteins Products Offered
5.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.8.5 Cytiva Recombinant Proteins Revenue by Product in 2024
5.8.6 Cytiva Recombinant Proteins Revenue by Application in 2024
5.8.7 Cytiva Recombinant Proteins Revenue by Geographic Area in 2024
5.8.8 Cytiva Recent Developments
5.9 Eurogentec
5.9.1 Eurogentec Corporation Information
5.9.2 Eurogentec Description, Business Overview
5.9.3 Eurogentec Recombinant Proteins Products Offered
5.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.9.5 Eurogentec Recombinant Proteins Revenue by Product in 2024
5.9.6 Eurogentec Recombinant Proteins Revenue by Application in 2024
5.9.7 Eurogentec Recombinant Proteins Revenue by Geographic Area in 2024
5.9.8 Eurogentec Recent Developments
5.10 GenScript Biotech Corporation
5.10.1 GenScript Biotech Corporation Corporation Information
5.10.2 GenScript Biotech Corporation Description, Business Overview
5.10.3 GenScript Biotech Corporation Recombinant Proteins Products Offered
5.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.10.5 GenScript Biotech Corporation Recombinant Proteins Revenue by Product in 2024
5.10.6 GenScript Biotech Corporation Recombinant Proteins Revenue by Application in 2024
5.10.7 GenScript Biotech Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.10.8 GenScript Biotech Corporation Recent Developments
5.11 Reprocell
5.11.1 Reprocell Corporation Information
5.11.2 Reprocell Description, Business Overview
5.11.3 Reprocell Recombinant Proteins Products Offered
5.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.11.5 Reprocell Recombinant Proteins Revenue by Product in 2024
5.11.6 Reprocell Recombinant Proteins Revenue by Application in 2024
5.11.7 Reprocell Recombinant Proteins Revenue by Geographic Area in 2024
5.11.8 Reprocell Recent Developments
5.12 BPS Bioscience
5.12.1 BPS Bioscience Corporation Information
5.12.2 BPS Bioscience Description, Business Overview
5.12.3 BPS Bioscience Recombinant Proteins Products Offered
5.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.12.5 BPS Bioscience Recombinant Proteins Revenue by Product in 2024
5.12.6 BPS Bioscience Recombinant Proteins Revenue by Application in 2024
5.12.7 BPS Bioscience Recombinant Proteins Revenue by Geographic Area in 2024
5.12.8 BPS Bioscience Recent Developments
5.13 Abnova Corporation
5.13.1 Abnova Corporation Corporation Information
5.13.2 Abnova Corporation Description, Business Overview
5.13.3 Abnova Corporation Recombinant Proteins Products Offered
5.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.13.5 Abnova Corporation Recombinant Proteins Revenue by Product in 2024
5.13.6 Abnova Corporation Recombinant Proteins Revenue by Application in 2024
5.13.7 Abnova Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.13.8 Abnova Corporation Recent Developments
5.14 ProSpec Tany TechnoGene
5.14.1 ProSpec Tany TechnoGene Corporation Information
5.14.2 ProSpec Tany TechnoGene Description, Business Overview
5.14.3 ProSpec Tany TechnoGene Recombinant Proteins Products Offered
5.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.14.5 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Product in 2024
5.14.6 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Application in 2024
5.14.7 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Geographic Area in 2024
5.14.8 ProSpec Tany TechnoGene Recent Developments
5.15 Ajinomoto
5.15.1 Ajinomoto Corporation Information
5.15.2 Ajinomoto Description, Business Overview
5.15.3 Ajinomoto Recombinant Proteins Products Offered
5.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.15.5 Ajinomoto Recombinant Proteins Revenue by Product in 2024
5.15.6 Ajinomoto Recombinant Proteins Revenue by Application in 2024
5.15.7 Ajinomoto Recombinant Proteins Revenue by Geographic Area in 2024
5.15.8 Ajinomoto Recent Developments
6 North America
6.1 North America Recombinant Proteins Market Size YoY Growth 2020-2031
6.2 North America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
6.3 North America Recombinant Proteins Revenue by Type (2020-2025)
6.4 North America Recombinant Proteins Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Recombinant Proteins Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Recombinant Proteins Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025)
7.4 Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025)
8 Europe
8.1 Europe Recombinant Proteins Market Size YoY Growth 2020-2031
8.2 Europe Recombinant Proteins Market Facts & Figures by Country (2020-2031)
8.3 Europe Recombinant Proteins Revenue by Type (2020-2025)
8.4 Europe Recombinant Proteins Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
9.2 Latin America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
9.3 Latin America Recombinant Proteins Revenue by Type (2020-2025)
9.4 Latin America Recombinant Proteins Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Recombinant Proteins Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025)
10.4 Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Recombinant Proteins Supply Chain Analysis
11.2 Recombinant Proteins Key Raw Materials and Upstream Suppliers
11.3 Recombinant Proteins Clients Analysis
11.4 Recombinant Proteins Sales Channel and Sales Model Analysis
11.4.1 Recombinant Proteins Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Recombinant Proteins Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Recombinant Proteins Distributors
12 Recombinant Proteins Market Dynamics
12.1 Recombinant Proteins Industry Trends
12.2 Recombinant Proteins Market Drivers
12.3 Recombinant Proteins Market Challenges
12.4 Recombinant Proteins Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Recombinant Proteins Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Proteins Market Size Estimates and Forecasts
2.2 Recombinant Proteins Market Size by Region: 2024 Versus 2031
2.2.1 Global Recombinant Proteins Revenue by Region: 2020-2025
2.2.2 Global Recombinant Proteins Revenue Forecast by Region (2026-2031)
2.2.3 Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Recombinant Proteins Revenue by Type (2020-2031)
3.1.2 Global Recombinant Proteins Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Recombinant Proteins Revenue by Application (2020-2031)
3.2.2 Global Recombinant Proteins Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Hormones of Recombinant Proteins Revenue Market Share by Application
3.3.2 Growth Factors of Recombinant Proteins Revenue Market Share by Application
3.3.3 Cytokines of Recombinant Proteins Revenue Market Share by Application
3.3.4 Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application
3.3.5 Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application
3.3.6 Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application
3.3.7 Others of Recombinant Proteins Revenue Market Share by Application
4 Global Recombinant Proteins by Company
4.1 Global Recombinant Proteins Revenue by Company (2020-2025)
4.2 Global Recombinant Proteins Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Recombinant Proteins Companies around the World: Ranking by Revenue
4.3.2 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Recombinant Proteins Companies Headquarters & Product Type
4.4.1 Global Recombinant Proteins Companies Headquarters
4.4.2 Date of International Companies Enter into Recombinant Proteins Market
4.4.3 Global Recombinant Proteins Companies Product & Service
4.4.4 Hormones Revenue Market Share of Recombinant Proteins by Company
4.4.5 Growth Factors Revenue Market Share of Recombinant Proteins by Company
4.4.6 Cytokines Revenue Market Share of Recombinant Proteins by Company
4.4.7 Plasma Protein Factor Revenue Market Share of Recombinant Proteins by Company
4.4.8 Recombinant Metabolic Enzymes Revenue Market Share of Recombinant Proteins by Company
4.4.9 Immune Checkpoint Regulators Revenue Market Share of Recombinant Proteins by Company
4.4.10 Others Revenue Market Share of Recombinant Proteins by Company
4.5 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bio-Techne Corporation
5.1.1 Bio-Techne Corporation Corporation Information
5.1.2 Bio-Techne Corporation Description, Business Overview
5.1.3 Bio-Techne Corporation Recombinant Proteins Products Offered
5.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.1.5 Bio-Techne Corporation Recombinant Proteins Revenue by Product in 2024
5.1.6 Bio-Techne Corporation Recombinant Proteins Revenue by Application in 2024
5.1.7 Bio-Techne Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.1.8 Bio-Techne Corporation Recent Developments
5.2 Abcam PLC
5.2.1 Abcam PLC Corporation Information
5.2.2 Abcam PLC Description, Business Overview
5.2.3 Abcam PLC Recombinant Proteins Products Offered
5.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.2.5 Abcam PLC Recombinant Proteins Revenue by Product in 2024
5.2.6 Abcam PLC Recombinant Proteins Revenue by Application in 2024
5.2.7 Abcam PLC Recombinant Proteins Revenue by Geographic Area in 2024
5.2.8 Abcam PLC Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Corporation Information
5.3.2 Merck KGaA Description, Business Overview
5.3.3 Merck KGaA Recombinant Proteins Products Offered
5.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.3.5 Merck KGaA Recombinant Proteins Revenue by Product in 2024
5.3.6 Merck KGaA Recombinant Proteins Revenue by Application in 2024
5.3.7 Merck KGaA Recombinant Proteins Revenue by Geographic Area in 2024
5.3.8 Merck KGaA Recent Developments
5.4 Miltenyi Biotec
5.4.1 Miltenyi Biotec Corporation Information
5.4.2 Miltenyi Biotec Description, Business Overview
5.4.3 Miltenyi Biotec Recombinant Proteins Products Offered
5.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.4.5 Miltenyi Biotec Recombinant Proteins Revenue by Product in 2024
5.4.6 Miltenyi Biotec Recombinant Proteins Revenue by Application in 2024
5.4.7 Miltenyi Biotec Recombinant Proteins Revenue by Geographic Area in 2024
5.4.8 Miltenyi Biotec Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Corporation Information
5.5.2 Thermo Fisher Scientific Description, Business Overview
5.5.3 Thermo Fisher Scientific Recombinant Proteins Products Offered
5.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.5.5 Thermo Fisher Scientific Recombinant Proteins Revenue by Product in 2024
5.5.6 Thermo Fisher Scientific Recombinant Proteins Revenue by Application in 2024
5.5.7 Thermo Fisher Scientific Recombinant Proteins Revenue by Geographic Area in 2024
5.5.8 Thermo Fisher Scientific Recent Developments
5.6 ACROBiosystems
5.6.1 ACROBiosystems Corporation Information
5.6.2 ACROBiosystems Description, Business Overview
5.6.3 ACROBiosystems Recombinant Proteins Products Offered
5.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.6.5 ACROBiosystems Recombinant Proteins Revenue by Product in 2024
5.6.6 ACROBiosystems Recombinant Proteins Revenue by Application in 2024
5.6.7 ACROBiosystems Recombinant Proteins Revenue by Geographic Area in 2024
5.6.8 ACROBiosystems Recent Developments
5.7 Sino Biological
5.7.1 Sino Biological Corporation Information
5.7.2 Sino Biological Description, Business Overview
5.7.3 Sino Biological Recombinant Proteins Products Offered
5.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.7.5 Sino Biological Recombinant Proteins Revenue by Product in 2024
5.7.6 Sino Biological Recombinant Proteins Revenue by Application in 2024
5.7.7 Sino Biological Recombinant Proteins Revenue by Geographic Area in 2024
5.7.8 Sino Biological Recent Developments
5.8 Cytiva
5.8.1 Cytiva Corporation Information
5.8.2 Cytiva Description, Business Overview
5.8.3 Cytiva Recombinant Proteins Products Offered
5.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.8.5 Cytiva Recombinant Proteins Revenue by Product in 2024
5.8.6 Cytiva Recombinant Proteins Revenue by Application in 2024
5.8.7 Cytiva Recombinant Proteins Revenue by Geographic Area in 2024
5.8.8 Cytiva Recent Developments
5.9 Eurogentec
5.9.1 Eurogentec Corporation Information
5.9.2 Eurogentec Description, Business Overview
5.9.3 Eurogentec Recombinant Proteins Products Offered
5.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.9.5 Eurogentec Recombinant Proteins Revenue by Product in 2024
5.9.6 Eurogentec Recombinant Proteins Revenue by Application in 2024
5.9.7 Eurogentec Recombinant Proteins Revenue by Geographic Area in 2024
5.9.8 Eurogentec Recent Developments
5.10 GenScript Biotech Corporation
5.10.1 GenScript Biotech Corporation Corporation Information
5.10.2 GenScript Biotech Corporation Description, Business Overview
5.10.3 GenScript Biotech Corporation Recombinant Proteins Products Offered
5.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.10.5 GenScript Biotech Corporation Recombinant Proteins Revenue by Product in 2024
5.10.6 GenScript Biotech Corporation Recombinant Proteins Revenue by Application in 2024
5.10.7 GenScript Biotech Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.10.8 GenScript Biotech Corporation Recent Developments
5.11 Reprocell
5.11.1 Reprocell Corporation Information
5.11.2 Reprocell Description, Business Overview
5.11.3 Reprocell Recombinant Proteins Products Offered
5.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.11.5 Reprocell Recombinant Proteins Revenue by Product in 2024
5.11.6 Reprocell Recombinant Proteins Revenue by Application in 2024
5.11.7 Reprocell Recombinant Proteins Revenue by Geographic Area in 2024
5.11.8 Reprocell Recent Developments
5.12 BPS Bioscience
5.12.1 BPS Bioscience Corporation Information
5.12.2 BPS Bioscience Description, Business Overview
5.12.3 BPS Bioscience Recombinant Proteins Products Offered
5.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.12.5 BPS Bioscience Recombinant Proteins Revenue by Product in 2024
5.12.6 BPS Bioscience Recombinant Proteins Revenue by Application in 2024
5.12.7 BPS Bioscience Recombinant Proteins Revenue by Geographic Area in 2024
5.12.8 BPS Bioscience Recent Developments
5.13 Abnova Corporation
5.13.1 Abnova Corporation Corporation Information
5.13.2 Abnova Corporation Description, Business Overview
5.13.3 Abnova Corporation Recombinant Proteins Products Offered
5.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.13.5 Abnova Corporation Recombinant Proteins Revenue by Product in 2024
5.13.6 Abnova Corporation Recombinant Proteins Revenue by Application in 2024
5.13.7 Abnova Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.13.8 Abnova Corporation Recent Developments
5.14 ProSpec Tany TechnoGene
5.14.1 ProSpec Tany TechnoGene Corporation Information
5.14.2 ProSpec Tany TechnoGene Description, Business Overview
5.14.3 ProSpec Tany TechnoGene Recombinant Proteins Products Offered
5.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.14.5 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Product in 2024
5.14.6 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Application in 2024
5.14.7 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Geographic Area in 2024
5.14.8 ProSpec Tany TechnoGene Recent Developments
5.15 Ajinomoto
5.15.1 Ajinomoto Corporation Information
5.15.2 Ajinomoto Description, Business Overview
5.15.3 Ajinomoto Recombinant Proteins Products Offered
5.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.15.5 Ajinomoto Recombinant Proteins Revenue by Product in 2024
5.15.6 Ajinomoto Recombinant Proteins Revenue by Application in 2024
5.15.7 Ajinomoto Recombinant Proteins Revenue by Geographic Area in 2024
5.15.8 Ajinomoto Recent Developments
6 North America
6.1 North America Recombinant Proteins Market Size YoY Growth 2020-2031
6.2 North America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
6.3 North America Recombinant Proteins Revenue by Type (2020-2025)
6.4 North America Recombinant Proteins Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Recombinant Proteins Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Recombinant Proteins Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025)
7.4 Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025)
8 Europe
8.1 Europe Recombinant Proteins Market Size YoY Growth 2020-2031
8.2 Europe Recombinant Proteins Market Facts & Figures by Country (2020-2031)
8.3 Europe Recombinant Proteins Revenue by Type (2020-2025)
8.4 Europe Recombinant Proteins Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
9.2 Latin America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
9.3 Latin America Recombinant Proteins Revenue by Type (2020-2025)
9.4 Latin America Recombinant Proteins Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Recombinant Proteins Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025)
10.4 Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Recombinant Proteins Supply Chain Analysis
11.2 Recombinant Proteins Key Raw Materials and Upstream Suppliers
11.3 Recombinant Proteins Clients Analysis
11.4 Recombinant Proteins Sales Channel and Sales Model Analysis
11.4.1 Recombinant Proteins Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Recombinant Proteins Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Recombinant Proteins Distributors
12 Recombinant Proteins Market Dynamics
12.1 Recombinant Proteins Industry Trends
12.2 Recombinant Proteins Market Drivers
12.3 Recombinant Proteins Market Challenges
12.4 Recombinant Proteins Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Recombinant Proteins Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Recombinant Proteins Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Recombinant Proteins Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Recombinant Proteins Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Recombinant Proteins Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 11. Recombinant Proteins Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Recombinant Proteins Players by Revenue (US$ Million) in 2024
Table 13. Global Recombinant Proteins Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Recombinant Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 15. Global Recombinant Proteins Companies Headquarters
Table 16. Date of International Companies Enter into Recombinant Proteins Market
Table 17. Global Recombinant Proteins Companies Product & Service
Table 18. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
Table 19. Bio-Techne Corporation Corporation Information
Table 20. Bio-Techne Corporation Description and Business Overview
Table 21. Bio-Techne Corporation Recombinant Proteins Product
Table 22. Bio-Techne Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 24. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 25. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 26. Bio-Techne Corporation Recent Developments
Table 27. Abcam PLC Corporation Information
Table 28. Abcam PLC Description and Business Overview
Table 29. Abcam PLC Recombinant Proteins Product
Table 30. Abcam PLC Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abcam PLC Revenue Proportion of Recombinant Proteins by Product in 2024
Table 32. Abcam PLC Revenue Proportion of Recombinant Proteins by Application in 2024
Table 33. Abcam PLC Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 34. Abcam PLC Recent Developments
Table 35. Merck KGaA Corporation Information
Table 36. Merck KGaA Description and Business Overview
Table 37. Merck KGaA Recombinant Proteins Product
Table 38. Merck KGaA Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Merck KGaA Revenue Proportion of Recombinant Proteins by Product in 2024
Table 40. Merck KGaA Revenue Proportion of Recombinant Proteins by Application in 2024
Table 41. Merck KGaA Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 42. Merck KGaA Recent Developments
Table 43. Miltenyi Biotec Corporation Information
Table 44. Miltenyi Biotec Description and Business Overview
Table 45. Miltenyi Biotec Recombinant Proteins Product
Table 46. Miltenyi Biotec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Product in 2024
Table 48. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Application in 2024
Table 49. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 50. Miltenyi Biotec Recent Developments
Table 51. Thermo Fisher Scientific Corporation Information
Table 52. Thermo Fisher Scientific Description and Business Overview
Table 53. Thermo Fisher Scientific Recombinant Proteins Product
Table 54. Thermo Fisher Scientific Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Product in 2024
Table 56. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Application in 2024
Table 57. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. ACROBiosystems Corporation Information
Table 60. ACROBiosystems Description and Business Overview
Table 61. ACROBiosystems Recombinant Proteins Product
Table 62. ACROBiosystems Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. ACROBiosystems Revenue Proportion of Recombinant Proteins by Product in 2024
Table 64. ACROBiosystems Revenue Proportion of Recombinant Proteins by Application in 2024
Table 65. ACROBiosystems Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 66. ACROBiosystems Recent Developments
Table 67. Sino Biological Corporation Information
Table 68. Sino Biological Description and Business Overview
Table 69. Sino Biological Recombinant Proteins Product
Table 70. Sino Biological Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Sino Biological Revenue Proportion of Recombinant Proteins by Product in 2024
Table 72. Sino Biological Revenue Proportion of Recombinant Proteins by Application in 2024
Table 73. Sino Biological Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 74. Sino Biological Recent Developments
Table 75. Cytiva Corporation Information
Table 76. Cytiva Description and Business Overview
Table 77. Cytiva Recombinant Proteins Product
Table 78. Cytiva Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cytiva Revenue Proportion of Recombinant Proteins by Product in 2024
Table 80. Cytiva Revenue Proportion of Recombinant Proteins by Application in 2024
Table 81. Cytiva Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 82. Cytiva Recent Developments
Table 83. Eurogentec Corporation Information
Table 84. Eurogentec Description and Business Overview
Table 85. Eurogentec Recombinant Proteins Product
Table 86. Eurogentec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Eurogentec Revenue Proportion of Recombinant Proteins by Product in 2024
Table 88. Eurogentec Revenue Proportion of Recombinant Proteins by Application in 2024
Table 89. Eurogentec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 90. Eurogentec Recent Developments
Table 91. GenScript Biotech Corporation Corporation Information
Table 92. GenScript Biotech Corporation Description and Business Overview
Table 93. GenScript Biotech Corporation Recombinant Proteins Product
Table 94. GenScript Biotech Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 96. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 97. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 98. GenScript Biotech Corporation Recent Developments
Table 99. Reprocell Corporation Information
Table 100. Reprocell Description and Business Overview
Table 101. Reprocell Recombinant Proteins Product
Table 102. Reprocell Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Reprocell Revenue Proportion of Recombinant Proteins by Product in 2024
Table 104. Reprocell Revenue Proportion of Recombinant Proteins by Application in 2024
Table 105. Reprocell Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 106. Reprocell Recent Developments
Table 107. BPS Bioscience Corporation Information
Table 108. BPS Bioscience Description and Business Overview
Table 109. BPS Bioscience Recombinant Proteins Product
Table 110. BPS Bioscience Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. BPS Bioscience Revenue Proportion of Recombinant Proteins by Product in 2024
Table 112. BPS Bioscience Revenue Proportion of Recombinant Proteins by Application in 2024
Table 113. BPS Bioscience Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 114. BPS Bioscience Recent Developments
Table 115. Abnova Corporation Corporation Information
Table 116. Abnova Corporation Description and Business Overview
Table 117. Abnova Corporation Recombinant Proteins Product
Table 118. Abnova Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Abnova Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 120. Abnova Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 121. Abnova Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 122. Abnova Corporation Recent Developments
Table 123. ProSpec Tany TechnoGene Corporation Information
Table 124. ProSpec Tany TechnoGene Description and Business Overview
Table 125. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 126. ProSpec Tany TechnoGene Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Product in 2024
Table 128. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Application in 2024
Table 129. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 130. ProSpec Tany TechnoGene Recent Developments
Table 131. Ajinomoto Corporation Information
Table 132. Ajinomoto Description and Business Overview
Table 133. Ajinomoto Recombinant Proteins Product
Table 134. Ajinomoto Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Ajinomoto Revenue Proportion of Recombinant Proteins by Product in 2024
Table 136. Ajinomoto Revenue Proportion of Recombinant Proteins by Application in 2024
Table 137. Ajinomoto Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 138. Ajinomoto Recent Developments
Table 139. North America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 140. North America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 141. North America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 142. North America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 143. Asia-Pacific Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
Table 144. Asia-Pacific Recombinant Proteins Revenue by Region (2026-2031) & (US$ Million)
Table 145. Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 146. Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 147. Europe Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 148. Europe Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 149. Europe Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 150. Europe Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 151. Latin America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 152. Latin America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 153. Latin America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 154. Latin America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 155. Middle East and Africa Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 156. Middle East and Africa Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 157. Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 158. Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 159. Recombinant Proteins Key Raw Materials, Industry Status and Trend
Table 160. Recombinant Proteins Key Raw Materials and Upstream Suppliers
Table 161. Recombinant Proteins Clients Status and Trend
Table 162. Recombinant Proteins Typical Clients
Table 163. Recombinant Proteins Distributors
Table 164. Recombinant Proteins Market Trends
Table 165. Recombinant Proteins Market Drivers
Table 166. Recombinant Proteins Market Challenges
Table 167. Recombinant Proteins Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Proteins Product Picture
Figure 2. Global Recombinant Proteins Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Recombinant Proteins Revenue Market Share by Type in 2024 & 2031
Figure 4. Hormones Product Picture
Figure 5. Growth Factors Product Picture
Figure 6. Cytokines Product Picture
Figure 7. Plasma Protein Factor Product Picture
Figure 8. Recombinant Metabolic Enzymes Product Picture
Figure 9. Immune Checkpoint Regulators Product Picture
Figure 10. Others Product Picture
Figure 11. Global Recombinant Proteins Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 12. Global Recombinant Proteins Revenue Market Share by Application in 2024 & 2031
Figure 13. Biopharmaceutical Companies
Figure 14. Academic and Research Institutes
Figure 15. Contract Research Organizations
Figure 16. Recombinant Proteins Report Years Considered
Figure 17. Global Recombinant Proteins Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Recombinant Proteins Market Size (2020-2031) & (US$ Million)
Figure 19. Global Recombinant Proteins Market Size Market Share by Region: 2024 Versus 2031
Figure 20. Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
Figure 21. Global Recombinant Proteins Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Global Recombinant Proteins Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Hormones of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 24. Growth Factors of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 25. Cytokines of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 26. Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 27. Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 28. Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 29. Others of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 30. Recombinant Proteins Revenue Share by Company (2024)
Figure 31. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Hormones Revenue Proportion by Company in 2024
Figure 33. Growth Factors Revenue Proportion by Company in 2024
Figure 34. Cytokines Revenue Proportion by Company in 2024
Figure 35. Plasma Protein Factor Revenue Proportion by Company in 2024
Figure 36. Recombinant Metabolic Enzymes Revenue Proportion by Company in 2024
Figure 37. Immune Checkpoint Regulators Revenue Proportion by Company in 2024
Figure 38. Others Revenue Proportion by Company in 2024
Figure 39. North America Recombinant Proteins Revenue 2020-2031 (US$ Million)
Figure 40. North America Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 41. North America Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 42. Asia-Pacific Recombinant Proteins Revenue 2020-2031 (US$ Million)
Figure 43. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2020-2031)
Figure 44. Asia-Pacific Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 45. Asia-Pacific Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 46. Europe Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Europe Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 48. Europe Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 49. Europe Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 50. Latin America Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 52. Latin America Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 53. Latin America Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 58. Recombinant Proteins Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Recombinant Proteins Raw Materials by Region in 2024
Figure 60. Recombinant Proteins Distribution Channels
Figure 61. Global Recombinant Proteins Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Recombinant Proteins Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Recombinant Proteins Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Recombinant Proteins Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Recombinant Proteins Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Recombinant Proteins Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Recombinant Proteins Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 11. Recombinant Proteins Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Recombinant Proteins Players by Revenue (US$ Million) in 2024
Table 13. Global Recombinant Proteins Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Recombinant Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 15. Global Recombinant Proteins Companies Headquarters
Table 16. Date of International Companies Enter into Recombinant Proteins Market
Table 17. Global Recombinant Proteins Companies Product & Service
Table 18. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
Table 19. Bio-Techne Corporation Corporation Information
Table 20. Bio-Techne Corporation Description and Business Overview
Table 21. Bio-Techne Corporation Recombinant Proteins Product
Table 22. Bio-Techne Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 24. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 25. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 26. Bio-Techne Corporation Recent Developments
Table 27. Abcam PLC Corporation Information
Table 28. Abcam PLC Description and Business Overview
Table 29. Abcam PLC Recombinant Proteins Product
Table 30. Abcam PLC Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abcam PLC Revenue Proportion of Recombinant Proteins by Product in 2024
Table 32. Abcam PLC Revenue Proportion of Recombinant Proteins by Application in 2024
Table 33. Abcam PLC Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 34. Abcam PLC Recent Developments
Table 35. Merck KGaA Corporation Information
Table 36. Merck KGaA Description and Business Overview
Table 37. Merck KGaA Recombinant Proteins Product
Table 38. Merck KGaA Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Merck KGaA Revenue Proportion of Recombinant Proteins by Product in 2024
Table 40. Merck KGaA Revenue Proportion of Recombinant Proteins by Application in 2024
Table 41. Merck KGaA Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 42. Merck KGaA Recent Developments
Table 43. Miltenyi Biotec Corporation Information
Table 44. Miltenyi Biotec Description and Business Overview
Table 45. Miltenyi Biotec Recombinant Proteins Product
Table 46. Miltenyi Biotec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Product in 2024
Table 48. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Application in 2024
Table 49. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 50. Miltenyi Biotec Recent Developments
Table 51. Thermo Fisher Scientific Corporation Information
Table 52. Thermo Fisher Scientific Description and Business Overview
Table 53. Thermo Fisher Scientific Recombinant Proteins Product
Table 54. Thermo Fisher Scientific Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Product in 2024
Table 56. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Application in 2024
Table 57. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. ACROBiosystems Corporation Information
Table 60. ACROBiosystems Description and Business Overview
Table 61. ACROBiosystems Recombinant Proteins Product
Table 62. ACROBiosystems Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. ACROBiosystems Revenue Proportion of Recombinant Proteins by Product in 2024
Table 64. ACROBiosystems Revenue Proportion of Recombinant Proteins by Application in 2024
Table 65. ACROBiosystems Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 66. ACROBiosystems Recent Developments
Table 67. Sino Biological Corporation Information
Table 68. Sino Biological Description and Business Overview
Table 69. Sino Biological Recombinant Proteins Product
Table 70. Sino Biological Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Sino Biological Revenue Proportion of Recombinant Proteins by Product in 2024
Table 72. Sino Biological Revenue Proportion of Recombinant Proteins by Application in 2024
Table 73. Sino Biological Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 74. Sino Biological Recent Developments
Table 75. Cytiva Corporation Information
Table 76. Cytiva Description and Business Overview
Table 77. Cytiva Recombinant Proteins Product
Table 78. Cytiva Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cytiva Revenue Proportion of Recombinant Proteins by Product in 2024
Table 80. Cytiva Revenue Proportion of Recombinant Proteins by Application in 2024
Table 81. Cytiva Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 82. Cytiva Recent Developments
Table 83. Eurogentec Corporation Information
Table 84. Eurogentec Description and Business Overview
Table 85. Eurogentec Recombinant Proteins Product
Table 86. Eurogentec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Eurogentec Revenue Proportion of Recombinant Proteins by Product in 2024
Table 88. Eurogentec Revenue Proportion of Recombinant Proteins by Application in 2024
Table 89. Eurogentec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 90. Eurogentec Recent Developments
Table 91. GenScript Biotech Corporation Corporation Information
Table 92. GenScript Biotech Corporation Description and Business Overview
Table 93. GenScript Biotech Corporation Recombinant Proteins Product
Table 94. GenScript Biotech Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 96. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 97. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 98. GenScript Biotech Corporation Recent Developments
Table 99. Reprocell Corporation Information
Table 100. Reprocell Description and Business Overview
Table 101. Reprocell Recombinant Proteins Product
Table 102. Reprocell Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Reprocell Revenue Proportion of Recombinant Proteins by Product in 2024
Table 104. Reprocell Revenue Proportion of Recombinant Proteins by Application in 2024
Table 105. Reprocell Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 106. Reprocell Recent Developments
Table 107. BPS Bioscience Corporation Information
Table 108. BPS Bioscience Description and Business Overview
Table 109. BPS Bioscience Recombinant Proteins Product
Table 110. BPS Bioscience Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. BPS Bioscience Revenue Proportion of Recombinant Proteins by Product in 2024
Table 112. BPS Bioscience Revenue Proportion of Recombinant Proteins by Application in 2024
Table 113. BPS Bioscience Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 114. BPS Bioscience Recent Developments
Table 115. Abnova Corporation Corporation Information
Table 116. Abnova Corporation Description and Business Overview
Table 117. Abnova Corporation Recombinant Proteins Product
Table 118. Abnova Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Abnova Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
Table 120. Abnova Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
Table 121. Abnova Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 122. Abnova Corporation Recent Developments
Table 123. ProSpec Tany TechnoGene Corporation Information
Table 124. ProSpec Tany TechnoGene Description and Business Overview
Table 125. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 126. ProSpec Tany TechnoGene Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Product in 2024
Table 128. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Application in 2024
Table 129. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 130. ProSpec Tany TechnoGene Recent Developments
Table 131. Ajinomoto Corporation Information
Table 132. Ajinomoto Description and Business Overview
Table 133. Ajinomoto Recombinant Proteins Product
Table 134. Ajinomoto Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Ajinomoto Revenue Proportion of Recombinant Proteins by Product in 2024
Table 136. Ajinomoto Revenue Proportion of Recombinant Proteins by Application in 2024
Table 137. Ajinomoto Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
Table 138. Ajinomoto Recent Developments
Table 139. North America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 140. North America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 141. North America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 142. North America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 143. Asia-Pacific Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
Table 144. Asia-Pacific Recombinant Proteins Revenue by Region (2026-2031) & (US$ Million)
Table 145. Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 146. Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 147. Europe Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 148. Europe Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 149. Europe Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 150. Europe Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 151. Latin America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 152. Latin America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 153. Latin America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 154. Latin America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 155. Middle East and Africa Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
Table 156. Middle East and Africa Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
Table 157. Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 158. Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 159. Recombinant Proteins Key Raw Materials, Industry Status and Trend
Table 160. Recombinant Proteins Key Raw Materials and Upstream Suppliers
Table 161. Recombinant Proteins Clients Status and Trend
Table 162. Recombinant Proteins Typical Clients
Table 163. Recombinant Proteins Distributors
Table 164. Recombinant Proteins Market Trends
Table 165. Recombinant Proteins Market Drivers
Table 166. Recombinant Proteins Market Challenges
Table 167. Recombinant Proteins Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Proteins Product Picture
Figure 2. Global Recombinant Proteins Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Recombinant Proteins Revenue Market Share by Type in 2024 & 2031
Figure 4. Hormones Product Picture
Figure 5. Growth Factors Product Picture
Figure 6. Cytokines Product Picture
Figure 7. Plasma Protein Factor Product Picture
Figure 8. Recombinant Metabolic Enzymes Product Picture
Figure 9. Immune Checkpoint Regulators Product Picture
Figure 10. Others Product Picture
Figure 11. Global Recombinant Proteins Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 12. Global Recombinant Proteins Revenue Market Share by Application in 2024 & 2031
Figure 13. Biopharmaceutical Companies
Figure 14. Academic and Research Institutes
Figure 15. Contract Research Organizations
Figure 16. Recombinant Proteins Report Years Considered
Figure 17. Global Recombinant Proteins Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Recombinant Proteins Market Size (2020-2031) & (US$ Million)
Figure 19. Global Recombinant Proteins Market Size Market Share by Region: 2024 Versus 2031
Figure 20. Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
Figure 21. Global Recombinant Proteins Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Global Recombinant Proteins Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Hormones of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 24. Growth Factors of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 25. Cytokines of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 26. Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 27. Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 28. Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 29. Others of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
Figure 30. Recombinant Proteins Revenue Share by Company (2024)
Figure 31. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Hormones Revenue Proportion by Company in 2024
Figure 33. Growth Factors Revenue Proportion by Company in 2024
Figure 34. Cytokines Revenue Proportion by Company in 2024
Figure 35. Plasma Protein Factor Revenue Proportion by Company in 2024
Figure 36. Recombinant Metabolic Enzymes Revenue Proportion by Company in 2024
Figure 37. Immune Checkpoint Regulators Revenue Proportion by Company in 2024
Figure 38. Others Revenue Proportion by Company in 2024
Figure 39. North America Recombinant Proteins Revenue 2020-2031 (US$ Million)
Figure 40. North America Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 41. North America Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 42. Asia-Pacific Recombinant Proteins Revenue 2020-2031 (US$ Million)
Figure 43. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2020-2031)
Figure 44. Asia-Pacific Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 45. Asia-Pacific Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 46. Europe Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Europe Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 48. Europe Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 49. Europe Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 50. Latin America Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 52. Latin America Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 53. Latin America Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Recombinant Proteins Revenue Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Recombinant Proteins Revenue Market Share by Application (2020-2025)
Figure 58. Recombinant Proteins Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Recombinant Proteins Raw Materials by Region in 2024
Figure 60. Recombinant Proteins Distribution Channels
Figure 61. Global Recombinant Proteins Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Recombinant Proteins Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232